Technology

Taking a small amount of LSD for treatment of depression proves safe for 'microdose'


Science

Taking a small amount of LSD for treatment of depression proves safe for 'microdose'

By Activedia

He says that he regularly takes very small amounts of hallucinogens using LSD.MicrodoseHas been proven in clinical trials.

Safety, tolerability, pharmacokinetics, and pharmacodynamics of low dose lysergic acid diethylamide (LSD) in healthy older volunteers | SpringerLink
https://link.springer.com/article/10.1007/s00213-019-05417-7

Eleusis Announces Phase 1 Trial Results of Lysergic Acid Diethylamide (LSD) in Healthy Older Volunteers, Potential to Evaluate as Disease Modifying Therapy for Alzheimer's Disease — Eleusis
https://www.eleusisltd.com/news/2019/12/18/eleusis-announces-phase-1-trial-results-of-lysergic-acid-diethylamide-lsd-in-healthy-older-volunteers-potential- to-evaluate-as-disease-modifying-therapy-for-alzheimers-disease

Microdosing LSD for Alzheimer ’s proves safe in early human trial
https://newatlas.com/science/microdosing-lsd-alzheimers-phase1-trial-results-safety/

"Microdose" is a treatment that relieves depression by taking very small doses of hallucinogens, such as LSD and magic mushrooms, on a regular basis. In the United States, hallucinogens are banned by law, but many report improvements in depression and cognitive abilities.

What is "LSD Microdose" that improves creativity and depression by taking a small amount of LSD? -GIGAZINE

A type of hallucinogenMagic mushroomThe active ingredient ofPsilocybin"SerotoninStimulate the receptordepressionWas suggested to improve. On November 27, 2019, psilocybin is used to treat depressive disorder (MDD)U.S. Food and Drug Administration(FDA)ByBreakthrough therapeuticsWas specified.

The same hallucinogen component as Magic Mushroom is approved by authorities as a “ breakthrough therapeutic agent '' for depression-gigazine

by Shutterbug75

This study evaluates the "safety" of microdose using LSD. Life science research companyEleusisFor 48 elderly volunteers with an average age of 62.9 years, a very small amount of 5 μg, 10 μg, and 20 μg LSD and a placeboplaceboWas administered every 4 days for a total of 6 doses.

After the experiment, in addition to physical tests such as blood pressure, heart rate, and ECG,Deep sense, Psychological calm / cognitive abilityPsychological reactionMental examinations such as were performed. The test results showed that although the number of reported headaches differed between the placebo group and the LSD group,TolerabilityNo harmful effects were detected in any of the doses of LSD, "said Eleusis.

There is controversy over the efficacy of microdosing of LSD. Held at the University of Chicago in early 2019the studyConcludes that "low doses of LSD do not affect mood, cognition, or physiological measurements." Meanwhile, UK research institutions such as the University of Londonthe studyHas shown that subjects receiving a small amount of LSD consistently "prolonged the length of time." The results suggest that LSD may be cognitively affected when administered in very small doses, even if you are not aware of it.

Copy the title and URL of this article

Source link

Do you like this article??

Show More

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button